Alessio Fasano, MD, from Massachusetts General Hospital, discusses the need for more novel tools to perform better research on celiac disease, his research on a new 3-dimensional model for studying the effect of microbiota-derived molecules in celiac disease, and more.

In this podcast, Peter Reaven, MD, discusses the effects of glucose variability on vascular disease outcomes, the results of the ACCORD and VADT trials, and how the trials' results have impacted clinical practice over the years. More at: www.consultant360.com/cardiology.

Dr Wei discusses her latest research, which found that patients with a first-degree relative who has had melanoma have a higher risk of multiple types of skin cancer.

In this podcast, Cherinne Arundel, MD, and her colleague Phillip Lam, MD, discuss their latest research study about systolic blood pressure and outcomes in patients with heart failure with reduced ejection fraction. More at: www.consultant360.com/cardiology.

In this podcast, Ralph Baric, PhD, from the University of North Carolina at Chapel Hill, discusses his latest research on the National Institute of Health's dengue vaccine, what the findings mean for the future development of vaccines, and more. More at: www.consultant360.com/infectious_diseases.

James D. Lewis, MD, MSCE, from the University of Pennsylvania, discusses the role of diet in Crohn disease, his research on the association between reduced consumption of red and processed meats and risk of symptomatic relapse of Crohn disease, and more.

In this podcast, Stewart Tepper, MD, talks about the science of cluster headache, the changes in the clinical management of cluster headache, and how recent treatment options have improved the management of cluster headache. More at: www.consultant360.com/neurology.

In this podcast, Matthew Robbins, MD, overviews the treatments for migraine that are currently available, assesses the risks and benefits of using each treatment in clinical practice, and explains how to use some of these treatments in special populations. More at: www.consultant360.com/neurology.

In this podcast, S. Thomas Carmichael, MD, PhD, discusses the roles of CREB, CCR5, and tonic GABA signaling in memory formation during stroke recovery, as well as other advances in regenerative medicine from the upcoming ANA 2019 annual meeting. More at: www.consultant360.com/neurology.

Dhyanesh A. Patel, MD, from Vanderbilt University Medical Center, highlights the current role of proton-pump inhibitors and related adverse effects, indications for their use, and more.